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Résumé en
anglais
In sepsis, inflammation and thrombosis are both the cause and the result of
interactions between circulating (for example, leukocytes and platelets), endothelial
and smooth muscle cells. Microparticles are proinflammatory and procoagulant
fragments originating from plasma membrane generated after cellular activation
and released in body fluids. In the vessel, they constitute a pool of bioactive
effectors pulled from diverse cellular origins and may act as intercellular
messengers. Microparticles expose phosphatidylserine, a procoagulant phospholipid
made accessible after membrane remodelling, and tissue factor, the initiator of
blood coagulation at the endothelial and leukocyte surface. They constitute a
secretion pathway for IL-1β and up-regulate the proinflammatory response of target
cells. Microparticles circulate at low levels in healthy individuals, but undergo
phenotypic and quantitative changes that could play a pathophysiological role in
inflammatory diseases. Microparticles may participate in the pathogenesis of sepsis
through multiple ways. They are able to regulate vascular tone and are potent
vascular proinflammatory and procoagulant mediators. Microparticles' abilities are
of increasing interest in deciphering the mechanisms underlying the multiple organ
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